All-Cause Mortality and Cardiovascular Outcomes With Prophylactic Steroid Therapy in Duchenne Muscular Dystrophy

Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology

Roberto M. Lang, Michelle Bierig, Richard B. Devereux et al. · Journal of the American Society of Echocardiography · 2005 · 11.3K citations

Standards Committee, Cardiovascular Disease, Patient Safety +13

Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management

K. Bushby, Richard S. Finkel, David J. Birnkrant et al. · The Lancet Neurology · 2009 · 2K citations

Part 1, Kinesiology, Psychiatry +9

Geometric method for measuring body surface area: A height-weight formula validated in infants, children, and adults

G B Haycock, George J. Schwartz, David H. Wisotsky · The Journal of Pediatrics · 1978 · 1.7K citations

Obesity, Childhood Obesity, Physical Activity +9

Dystrophin protects the sarcolemma from stresses developed during muscle contraction.

Basil J. Petrof, Joseph B. Shrager, Hansell H. Stedman et al. · Proceedings of the National Academy of Sciences · 1993 · 1.5K citations · Full text

Muscle Function, Engineering, Pathology +17

Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation

Michelle Eagle, Simon Baudouin, Colin Chandler et al. · Neuromuscular Disorders · 2002 · 989 citations

Home Nocturnal Ventilation, Longevity, Duchenne Muscular Dystrophy +10